<\/p>\n
NEW FILINGS<\/p>\n
Company: Inhibrx, Inc.
\nSymbol: INBX
\nDescription: They are a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Evercore ISI, Barclays, Nomura
\nCo-Manager(s): Raymond James
\nFiled 6-3-19
\nListed Cash Raise: $74.5m<\/p>\n
Company: Karuna Therapeutics, Inc
\nSymbol: KRTX
\nDescription: They are an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Citigroup, Wells Fargo
\nCo-Manager(s): Wedbush PacGrow
\nFiled: 5-31-19
\nListed Cash Raise: $75m<\/p>\n
Company: The RealReal, Inc.
\nSymbol: REAL
\nDescription: The RealReal is the world\u2019s largest online marketplace for authenticated, consigned luxury goods.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, BofA Merrill Lynch, UBS Investment Bank
\nCo-Manager(s): KeyBanc Capital, Stifel, Cowen, Raymond James
\nFiled: 5-31-19
\nListed Cash Raise: $100m<\/p>\n
TERMS ADDED<\/p>\n
Company: Personalis, Inc.
\nSymbol: PSNL
\nDescription: They are a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient\u2019s cancer and immune response.
\nShares: 6.67 million
\nPrice Range: $14.00-$16.00
\nTrade Date: Thursday, 6\/20
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen
\nCo-Manager(s): Oppenheimer & Co.
\nTerms Added: 6-7-19<\/p>\n
Company: Stoke Therapeutics, Inc.
\nSymbol: STOK
\nDescription: They are pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.
\nShares: 6.7 million
\nPrice Range: $14.00-$16.00
\nTrade Date: Thursday, 6\/20
\nUnderwriter(s): JP Morgan, Cowen, Credit Suisse
\nCo-Manager(s): Canaccord Genuity
\nTerms Added: 6-7-19<\/p>\n
Company: Fiverr International Ltd.
\nSymbol: FVRR
\nDescription: They started with the simple idea that people should be able to buy and sell digital services in the same fashion as physical goods on an e-commerce platform.
\nShares: 5.26 million
\nPrice Range: $18.00-$21.00
\nTrade Date: Thursday, 6\/13
\nUnderwriter(s): JP Morgan, Citigroup, BofA Merrill Lynch, UBS Investment Bank
\nCo-Manager(s): JMP Securities, Needham & Co., Oppenheimer,
\nTerms Added: 6-3-19<\/p>\n
Company: Chewy, Inc.
\nSymbol: CHWY
\nDescription: Their mission is to be the most trusted and convenient online destination for pet parents everywhere.
\nShares: 41.6 million
\nPrice Range: $17.00-$19.00
\nTrade Date: Friday, 6\/14
\nUnderwriter(s): Morgan Stanley, JP Morgan, Allen & Co., BofA Merrill Lynch, Barclays, Jefferies, RBC Capital, UBS, Wells Fargo
\nCo-Manager(s): Nomura, Raymond James, William Blair
\nTerms Added: 6-3-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-8542","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=8542"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8542\/revisions"}],"predecessor-version":[{"id":8543,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8542\/revisions\/8543"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=8542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=8542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=8542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}